Xavier Champavere

Co-founder of Thinkeen Europe, Xavier Champavere has gathered over 30 years of experience in the life science sector including 15 years in the vaccine industry with Aventis Pasteur MSD and general management positions in France and Argentina, the U.K., Italy and Greece. Today he is also non-executive director to the board of Moleac Pte (biopharmaceutical ). In 2012, Champavere joined Cellectis Bioresearch, a global leader in gene editing and cell line engineering, as deputy CEO. Previously he held key leadership positions in the service industry, CRM, CSO and CRO, for the pharmaceutical companies Cegedim CRM and Data Collection, Cider Santé and Arvem CS. Other positions have included: BUD for France, Belgium and Luxembourg at Serono Biotech, managing director in Italy and France at Sanofi Pasteur MSD and director of commercial development in the U.K. and Ireland. X Champavere holds a PhD in biochemical engineering from the University of Compiègne and is an alumnus of INSEAD, ESCP and Henley Management College executive programs.